In conclusion, we have shown that glycosphingolipid (GSL)-depletion by inhibition of glucosylceramide synthase, the major enzyme involved in the initial step of GSL-biosynthesis, led to growth retardation of colon cancer cell-derived tumor microspheres and to an arrest of the cell cycle. The gene discussed is UGCG; the disease is neoplasm.